Newbury Pharmaceuticals AB (publ)
STO: NEWBRY.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Karl Alexius Tiger Karlsson
- Employees
- 6
- Headquarters
- Lund, Sweden
- IPO year
- 2022
- Market cap
- SEK 35.6M
- Website
- https://www.newburypharma.com
Loading NEWBRY…
Loading profile data…Frequently asked questions about NEWBRY
What does Newbury Pharmaceuticals AB (publ) (NEWBRY.ST) do?
Newbury Pharmaceuticals AB (publ) operates as hybrid pharmaceutical company in Sweden, and Scandinavian market. It offers oncology, rare diseases, neurology, and other treatment products. The company was incorporated in 2020 and is based in Lund, Sweden.
Where does NEWBRY.ST trade?
Newbury Pharmaceuticals AB (publ) (NEWBRY.ST) trades on the Stockholm Stock Exchange.
What sector is NEWBRY.ST in?
Newbury Pharmaceuticals AB (publ) (NEWBRY.ST) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Newbury Pharmaceuticals AB (publ)?
Karl Alexius Tiger Karlsson is the chief executive officer of Newbury Pharmaceuticals AB (publ) (NEWBRY.ST).
Where is Newbury Pharmaceuticals AB (publ) headquartered?
Newbury Pharmaceuticals AB (publ) is headquartered in Sweden.
Does NEWBRY.ST pay a dividend?
Newbury Pharmaceuticals AB (publ) (NEWBRY.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NEWBRY.ST go public?
Newbury Pharmaceuticals AB (publ) (NEWBRY.ST) completed its initial public offering in 2022.